European regulators have recommended expanding Maviret, a dual direct-acting antiviral, to include acute hepatitis C infection in adults and children.
Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral ...
As the opioid epidemic has worsened in the United States, prevalence of hepatitis C has also increased. Hepatitis C is a bloodborne virus that damages the liver. It is mainly spread through sharing ...
MedPage Today on MSN
FDA OKs first treatment for chronic hepatitis D infection
In phase III study, patients taking bulevirtide had ALT normalization and steep drops in H ...
U ntil recently, most people diagnosed with hepatitis C were baby boomers, many of whom got the infection via a blood transfusion. As of 2024, hepatitis C is mostly spread via needles, syringes, and ...
AbbVie said the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion recommending the approval of its treatment for acute hepatitis C. The final ...
ALL CLEAR: “I don't have to worry about [hepatitis C] anymore or worry about it progressively getting worse,” says Maia Hughes, who sought treatment for HCV in 2018. She cleared the virus from her ...
Hepatitis C is a disease that affects the liver. Living with hepatitis C for a long time can damage your liver to the point where it doesn’t work very well. Early treatment can help protect your liver ...
This story is part of a larger series on viroids and virusoids, small infectious RNAs. It is also the seventh installment in a series on hepatitis D virus, a virusoid-like pathogen that causes serious ...
Hepatitis C and opioid use disorder are both chronic but treatable conditions. Yet many Americans living with this deadly combination aren’t offered treatment. Imagine going to your doctor with strep ...
MANCHESTER and LONDON, England — Alison Starkie spends her days tracking down people who need testing or treatment for hepatitis C, especially those who are unhoused or actively using drugs. Starkie, ...
Additional Data Presented Demonstrate High In Vitro Antiviral Potency and In Vivo Efficacy for AT-587, Atea’s Potential First ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results